Vaccines

04 May 2016 SELLAS Life Sciences Announces Positive WT1 Cancer Vaccine (galinpepimut-S) Clinical Results at the 13th International Conference of the International Mesothelioma Interest Group (iMig)
04 May 2016 VAXIMM initiates Phase 2a study in advanced colorectal cancer with oral T-cell vaccine VXM01
02 May 2016 Pharos Biologicals Conducting Tests of a Novel Zika Vaccine
02 May 2016 SELLAS Life Sciences Group Announces Initiation of Galinpepimut-S (WT1 Cancer Vaccine) Phase 1 Clinical Trial in Combination with PD-1 Checkpoint Inhibitor for Patients with Ovarian Cancer
29 Apr 2016 CyTuVax Reports Interim Results of the Phase I Clinical Trial with the HBAI20 Hepatitis B Vaccine for Non-Responders
26 Apr 2016 Journal of the American Medical Association Publishes Phase III Data from Allergic Asthma Trial with ALK's House Dust Mite SLIT-tablet, ACARIZAX
21 Apr 2016 TapImmune Announces Phase 2 Ovarian Cancer Trial Study with AstraZeneca/MedImmune and Sloan Kettering Cancer Institute
19 Apr 2016 Global Public-Private Partnership Announces Publication of Positive Phase 1 Data for Ebola Vaccine Regimen in JAMA
19 Apr 2016 Galena Biopharma Presents GALE-301/GALE-302 Clinical Booster Data at the American Association for Cancer Research (AACR) Annual Meeting
13 Apr 2016 PDS Biotechnology Reports Positive Phase 1 Study Results for PDS0101 Immunotherapy for HPV-Related Cancers
13 Apr 2016 Merck Announces FDA Acceptance of Biologics License Application for Investigational House Dust Mite Sublingual Allergy Immunotherapy Tablet
12 Apr 2016 DBV Technologies Announces Publication of Experimental Data on Targeted Regulatory T Cell Induction during Epicutaneous Immunotherapy
11 Apr 2016 Aimmune Therapeutics Presents Data on Biomarkers and Potential to Predict Response to Peanut Allergy Treatment With AR101
05 Apr 2016 Mymetics Announces Successful Preclinical Results With Malaria Transmission-Blocking Vaccine Candidate
02 Apr 2016 Pandemic influenza vaccine receives positive CHMP opinion
02 Apr 2016 PJSC Pharmsynthez Completes Follow Up and Data Analysis From a Phase 2 Study of Novel Therapeutic Vaccine Xemys(TM) for Multiple Sclerosis
01 Apr 2016 Medigene announces Start of Phase II trial with DC vaccines and upcoming milestone payment
31 Mar 2016 GeoVax Extends Research Collaborations on Zika Vaccine
31 Mar 2016 Genital Herpes Immunotherapy GEN-003 Shows Sustained Reduction of Viral Shedding Rate, Durable Impact on Clinical Disease 12 Months Post-Dosing
31 Mar 2016 Inovio Ebola Vaccine Generates Robust Immune Responses in Humans
31 Mar 2016 Inovio Updates INO-3112 HPV Immunotherapy Development Plan
29 Mar 2016 BiondVax's Universal Flu Vaccine Phase 2b Clinical Trial Recruitment Complete
25 Mar 2016 New findings in humans provide encouraging foundation for upcoming AIDS vaccine clinical trial
23 Mar 2016 Argos Therapeutics Announces Initiation of a Phase 2 Clinical Trial of AGS-003 for the Treatment of Non-small Cell Lung Cancer in Combination with Standard-of-Care Chemotherapy
19 Mar 2016 AXON Presented Its Tau Vaccine in Two Presentations at 14Th AAT Conference

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top